Paper3133573
Effect of L-threo-3,4-dihydroxyphenylserine on muscle sympathetic nerve activities in Shy-Drager syndrome.
Kachi T and 5 others. Neurology, 1988. Cited by 54 papers, by iCite.
Cite this record
ConductScience Library. Effect of L-threo-3,4-dihydroxyphenylserine on muscle sympathetic nerve activities in Shy-Drager syndrome. Papers, record 3133573. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3133573
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Effect of L-threo-3,4-dihydroxyphenylserine on muscle sympathetic nerve activities in Shy-Drager syndrome.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Autonomic Nervous System Diseases | Major topic |
| Droxidopa | Major topic |
| Muscles | Major topic |
| Serine | Major topic |
| Shy-Drager Syndrome | Major topic |
| Sympathetic Nervous System | Major topic |
| Tibial Nerve | Major topic |
| Blood Pressure | |
| Efferent Pathways | |
| Humans | |
| Male | |
| Middle Aged | |
| Norepinephrine |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT01176240 | A Two Part Study (306A/306B) to Assess Droxidopa in Treatment of NOH in Patients With Parkinson's Disease | Background |
Source ClinicalTrials.gov
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 54 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39751950 | Diagnosis and treatment of autonomic failure, pain and sleep disturbances in Parkinson's disease: guideline "Parkinson's disease" of the German Society of Neurology. | J Neurol | 2025 | https://conductscience.org/library/papers/39751950 | PubMed |
| 33815139 | Autonomic Function in Patients With Parkinson's Disease: From Rest to Exercise. | Front Physiol | 2021 | https://conductscience.org/library/papers/33815139 | PubMed |
| 32894454 | Drug-Related Orthostatic Hypotension: Beyond Anti-Hypertensive Medications. | Drugs Aging | 2020 | https://conductscience.org/library/papers/32894454 | PubMed |
| 32435491 | Altered cardiorespiratory regulation during exercise in patients with Parkinson's disease: A challenging non-motor feature. | SAGE Open Med | 2020 | https://conductscience.org/library/papers/32435491 | PubMed |
| 29058089 | Evidence-based treatment of neurogenic orthostatic hypotension and related symptoms. | J Neural Transm (Vienna) | 2017 | https://conductscience.org/library/papers/29058089 | PubMed |
| 28713844 | Epidemiology, Diagnosis, and Management of Neurogenic Orthostatic Hypotension. | Mov Disord Clin Pract | 2017 | https://conductscience.org/library/papers/28713844 | PubMed |
| 28623419 | Droxidopa for symptomatic neurogenic orthostatic hypotension: what can we learn? | Clin Auton Res | 2017 | https://conductscience.org/library/papers/28623419 | PubMed |
| 28124174 | The Clinical Autonomic Research journal 2017 and onward. | Clin Auton Res | 2017 | https://conductscience.org/library/papers/28124174 | PubMed |
| 27826809 | Vasomotor regulation in patients with multiple system atrophy. | J Neural Transm (Vienna) | 2017 | https://conductscience.org/library/papers/27826809 | PubMed |
| 26092297 | Droxidopa in neurogenic orthostatic hypotension. | Expert Rev Cardiovasc Ther | 2015 | https://conductscience.org/library/papers/26092297 | PubMed |
| 25309444 | Role of sympathetic nerve activity in the process of fainting. | Front Physiol | 2014 | https://conductscience.org/library/papers/25309444 | PubMed |
| 11710796 | L-threo-dihydroxyphenylserine (L-threo-DOPS; droxidopa) in the management of neurogenic orthostatic hypotension: a multi-national, multi-center, dose-ranging study in multiple system atrophy and pure autonomic failure. | Clin Auton Res | 2001 | https://conductscience.org/library/papers/11710796 | PubMed |
| 8902314 | The effects of the noradrenaline precursor, L-threo-3,4-dihydroxyphenylserine, in children with orthostatic intolerance. | Clin Auton Res | 1996 | https://conductscience.org/library/papers/8902314 | PubMed |
| 8676171 | Acute pandysautonomia: mass spectrometric and histopathological studies of the sympathetic nervous system during long term L-threo-3,4-dihydroxyphenylserine treatment. | J Neurol Neurosurg Psychiatry | 1996 | https://conductscience.org/library/papers/8676171 | PubMed |
| 8324376 | Microneurographic analysis of muscle sympathetic nerve activity in amyotrophic lateral sclerosis. | Clin Auton Res | 1993 | https://conductscience.org/library/papers/8324376 | PubMed |
| 2283531 | Shy-Drager syndrome. Effect of fludrocortisone and L-threo-3,4-dihydroxyphenylserine on the blood pressure and regional cerebral blood flow. | J Neurol Neurosurg Psychiatry | 1990 | https://conductscience.org/library/papers/2283531 | PubMed |
| 2029394 | Otoneurological manifestations of the Shy-Drager syndrome. | Eur Arch Otorhinolaryngol | 1991 | https://conductscience.org/library/papers/2029394 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| TPO | 7173 | PubTator's text mining | https://conductscience.org/library/genes/7173 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3133573
GET https://conductscience.org/api/papers/v1/3133573/authors